Pages that link to "Q39188922"
Jump to navigation
Jump to search
The following pages link to Alfonso Carotenuto (Q39188922):
Displaying 50 items.
- Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists (Q27727757) (← links)
- Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis. (Q30655228) (← links)
- Structural studies on Hgr3 orphan receptor ligand prolactin-releasing peptide (Q30750634) (← links)
- Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis (Q33254200) (← links)
- A different molecular mechanism underlying antimicrobial and hemolytic actions of temporins A and L. (Q33325986) (← links)
- New insight into the mechanism of action of the temporin antimicrobial peptides (Q33524875) (← links)
- Structure-activity relationship, conformational and biological studies of temporin L analogues (Q33820070) (← links)
- An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis (Q33900554) (← links)
- Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor (Q33926210) (← links)
- Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity (Q34324528) (← links)
- Novel α-MSH peptide analogues with broad spectrum antimicrobial activity (Q34692222) (← links)
- Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation (Q34693841) (← links)
- Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors (Q35001905) (← links)
- De novo designed library of linear helical peptides: an exploratory tool in the discovery of protein-protein interaction modulators (Q35145940) (← links)
- Urotensin-II receptor peptide agonists (Q35821444) (← links)
- Urotensin-II receptor antagonists. (Q36395578) (← links)
- Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma. (Q37718142) (← links)
- New anticancer agents mimicking protein recognition motifs (Q39121427) (← links)
- Synthesis, in vitro, and in cell studies of a new series of [indoline-3,2'-thiazolidine]-based p53 modulators (Q39134742) (← links)
- Opposite modulation of cell migration by distinct subregions of urokinase connecting peptide (Q39177238) (← links)
- Characterization of a selective CaMKII peptide inhibitor (Q39197137) (← links)
- Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors. (Q39306263) (← links)
- Design, synthesis, and cytotoxic evaluation of acyl derivatives of 3-aminonaphtho[2,3-b]thiophene-4,9-dione, a quinone-based system (Q39546096) (← links)
- Identification of the spiro(oxindole-3,3'-thiazolidine)-based derivatives as potential p53 activity modulators (Q39634535) (← links)
- Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors (Q39674536) (← links)
- New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide (Q39853266) (← links)
- Spiro[(dihydropyrazin-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)]-based cytotoxic agents: structure-activity relationship studies on the substituent at N4-position of the diketopiperazine domain (Q39989532) (← links)
- Novel sst5-selective somatostatin dicarba-analogues: synthesis and conformation-affinity relationships (Q40022169) (← links)
- Design, synthesis, and cytotoxic evaluation of a new series of 3-substituted spiro[(dihydropyrazine-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)] derivatives (Q40156105) (← links)
- An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule (Q41033958) (← links)
- The effect of d-amino acid substitution on the selectivity of temporin L towards target cells: identification of a potent anti-Candida peptide (Q41408690) (← links)
- Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor (Q41507159) (← links)
- Novel cyclic biphalin analogue with improved antinociceptive properties. (Q41838525) (← links)
- Synthesis and pharmacological evaluation of some 4-oxo-quinoline-2-carboxylic acid derivatives as anti-inflammatory and analgesic agents (Q42861765) (← links)
- Design and synthesis of spirotryprostatin-inspired diketopiperazine systems from prolyl spirooxoindolethiazolidine derivatives (Q43059716) (← links)
- New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide (Q44114224) (← links)
- A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge (Q44142617) (← links)
- Retroinverso analogue of the antiviral octapeptide C8 inhibits feline immunodeficiency virus in serum. (Q44424774) (← links)
- Unraveling the active conformation of urotensin II. (Q44803447) (← links)
- Development of antiviral fusion inhibitors: short modified peptides derived from the transmembrane glycoprotein of feline immunodeficiency virus (Q45418450) (← links)
- Designed glucopeptides mimetics of myelin protein epitopes as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis. (Q45956279) (← links)
- Designed glycopeptides with different beta-turn types as synthetic probes for the detection of autoantibodies as biomarkers of multiple sclerosis (Q46422616) (← links)
- Morphiceptin analogues containing a dipeptide mimetic structure: an investigation on the bioactive topology at the mu-receptor (Q46460059) (← links)
- Urotensin-II receptor ligands. From agonist to antagonist activity (Q46798118) (← links)
- Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration. (Q47334054) (← links)
- Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist (Q47417227) (← links)
- Structure-Activity Relationship Studies, SPR Affinity Characterization, and Conformational Analysis of Peptides That Mimic the HNK-1 Carbohydrate Epitope. (Q48283928) (← links)
- SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors (Q50939912) (← links)
- Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells. (Q52664347) (← links)
- An investigation into the origin of the biased agonism associated with the urotensin II receptor activation. (Q53165879) (← links)